journal article·2024-02

Revealing the Mutually Enhanced Mechanism of Necroptosis and Immunotherapy Induced by Defect Engineering and Piezoelectric Effect

Yaqian Du, Jiani Yang, Fei He, Xudong Zhao, Jialing Zhou, Pengyu Zang, Changlin Liu, Ying Xie, Yanqiao Zhang, Piaoping Yang

Advanced Materials· Volume 36· Issue 6
Publisher page

Abstract

Abstract Owing to low immunogenicity‐induced immune escape and short‐term circulating immune responses, the efficiency of immunotherapy is unsatisfactory. Therefore, triggering immunogenic cell death and establishing a long‐term, mutually reinforced treatment modality are urgent challenges. In this study, ultrathin CaBi2Nb2O9 nanosheets with tunable oxygen vacancies (abbreviated as CBNO‐OV1) are prepared for synergistic necroptosis and immunotherapy. The optimized vacancy concentration significantly improves the piezoelectric effect under ultrasound irradiation, thereby considerably improving the generation of reactive oxygen species (ROS). Density functional theory shows that oxygen vacancies can improve the efficiency of electron hole separation by suppressing their recombination, thus resulting in enhanced piezocatalytic activity. Moreover, the piezoelectric effect improves the permeability of tumor cell membranes, thus resulting in Ca2+ influx. Additionally, CBNO‐OV1 also releases a portion of Ca2+, which induces necroptosis assisted by explosive ROS. Ribonucleic acid transcription tests suggest the mechanisms associated with immune response activation and necroptosis. More importantly, necroptosis can trigger a significant immune response in vivo, thus activating macrophage M1 polarization through the NF‐kappa B pathway and promoting T‐cell differentiation.Tumor Necrosis Factor‐α differentiated from macrophages conversely promotes necroptosis, thus realizing a mutually enhanced effect. This study demonstrates the feasibility of mutually reinforced necroptosis and immunotherapy for amplifying tumor efficacy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Biosensors and Analytical Detection · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Superlight Materials and Surface Technology Ministry of Education College of Material Science and Chemical Engineering Harbin Engineering University Harbin 150001 P. R. China

Department of Gastrointestinal Medical Oncology Harbin Medical University Cancer Hospital Harbin 150001 P. R. China

Key Laboratory of Functional Inorganic Material Chemistry Ministry of Education School of Chemistry and Materials Science Heilongjiang University Harbin 150001 P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Heilongjiang Province · Natural Science Foundation of Shandong Province

References (73)

Show source-provided references
1. 10.1038/nnano.2016.28010.1038/nnano.2016.280 ↗
2. 10.1002/adma.20180066210.1002/adma.201800662 ↗
3. 10.3390/cancers1301013110.3390/cancers13010131 ↗
4. 10.1039/C9CS00648F10.1039/C9CS00648F ↗
5. 10.1016/j.apsb.2019.08.00310.1016/j.apsb.2019.08.003 ↗
6. 10.1002/adma.20230068710.1002/adma.202300687 ↗
7. 10.1002/adma.20210484910.1002/adma.202104849 ↗
8. 10.1002/adma.20180638110.1002/adma.201806381 ↗
9. 10.1002/anie.20200838610.1002/anie.202008386 ↗
10. 10.1002/adma.20200345810.1002/adma.202003458 ↗
11. 10.1002/anie.20210639210.1002/anie.202106392 ↗
12. 10.1002/adma.20130194610.1002/adma.201301946 ↗
13. 10.1002/adfm.20160147810.1002/adfm.201601478 ↗
14. 10.1002/adma.20200861510.1002/adma.202008615 ↗
15. 10.1002/adma.20220197810.1002/adma.202201978 ↗
16. 10.1039/C1CS15187H10.1039/C1CS15187H ↗
17. 10.1038/ncomms1043710.1038/ncomms10437 ↗
18. 10.1038/s41467-018-04571-410.1038/s41467-018-04571-4 ↗
19. 10.1002/adma.20200478810.1002/adma.202004788 ↗
20. 10.1002/adma.20180247910.1002/adma.201802479 ↗
21. 10.1002/anie.20200511110.1002/anie.202005111 ↗
22. Zheng P. · Angew. Chem., Int. Ed. · 2022 · 61
23. 10.1002/anie.20190628810.1002/anie.201906288 ↗
24. 10.1016/j.trecan.2021.09.00310.1016/j.trecan.2021.09.003 ↗
25. 10.1038/ncomms1432910.1038/ncomms14329 ↗
26. 10.1038/s41392-022-01046-310.1038/s41392-022-01046-3 ↗
27. 10.1016/j.celrep.2014.04.02610.1016/j.celrep.2014.04.026 ↗
28. 10.1002/adma.20220691510.1002/adma.202206915 ↗
29. 10.1038/ncb288310.1038/ncb2883 ↗
30. 10.1002/adma.20200506210.1002/adma.202005062 ↗
31. 10.1002/adfm.20211178410.1002/adfm.202111784 ↗
32. 10.1021/acsnano.1c0677710.1021/acsnano.1c06777 ↗
33. 10.1016/j.ccr.2022.21442310.1016/j.ccr.2022.214423 ↗
34. 10.1021/cr400425h10.1021/cr400425h ↗
35. 10.1021/acs.chemrev.5b0014810.1021/acs.chemrev.5b00148 ↗
36. 10.1002/adfm.20211208310.1002/adfm.202112083 ↗
37. 10.1002/adma.20160201210.1002/adma.201602012 ↗
38. 10.1002/adma.20200197610.1002/adma.202001976 ↗
39. 10.1038/s41467-021-24882-310.1038/s41467-021-24882-3 ↗
40. 10.1016/j.nantod.2020.10100910.1016/j.nantod.2020.101009 ↗
41. 10.1016/j.nanoen.2021.10583110.1016/j.nanoen.2021.105831 ↗
42. 10.1016/j.apcatb.2020.11970910.1016/j.apcatb.2020.119709 ↗
43. 10.1021/jacs.1c0351010.1021/jacs.1c03510 ↗
44. 10.1002/adma.20220255810.1002/adma.202202558 ↗
45. 10.1002/anie.20181396710.1002/anie.201813967 ↗
46. 10.1016/j.cej.2021.13393010.1016/j.cej.2021.133930 ↗
47. 10.1002/adma.20210683810.1002/adma.202106838 ↗
48. 10.1002/adma.20170048710.1002/adma.201700487 ↗
49. 10.1002/adma.20160273810.1002/adma.201602738 ↗
50. 10.1038/ki.2011.45010.1038/ki.2011.450 ↗
51. 10.1126/science.124936110.1126/science.1249361 ↗
52. 10.1038/nature1419110.1038/nature14191 ↗
53. 10.1038/s41586-019-1770-610.1038/s41586-019-1770-6 ↗
54. Snyder A. G. · Sci. Immunol. · 2019 · 4 · 36
55. 10.1016/j.semcancer.2022.03.00910.1016/j.semcancer.2022.03.009 ↗
56. 10.1038/s41586-022-04753-710.1038/s41586-022-04753-7 ↗
57. 10.1038/nrc.2017.9610.1038/nrc.2017.96 ↗
58. 10.1158/2159-8290.CD-20-080510.1158/2159-8290.CD-20-0805 ↗
59. 10.1002/advs.20190010110.1002/advs.201900101 ↗
60. 10.1016/j.ccr.2019.01.02010.1016/j.ccr.2019.01.020 ↗
61. 10.1002/advs.20210344410.1002/advs.202103444 ↗
62. 10.1016/j.cmet.2018.02.02410.1016/j.cmet.2018.02.024 ↗
63. 10.1021/acs.chemrev.7b0025810.1021/acs.chemrev.7b00258 ↗
64. 10.1002/adma.20170044810.1002/adma.201700448 ↗
65. 10.1002/anie.20191147710.1002/anie.201911477 ↗
66. 10.1038/s41565-022-01098-010.1038/s41565-022-01098-0 ↗
67. 10.1002/adma.20180829410.1002/adma.201808294 ↗
68. 10.1016/j.apsb.2021.05.01610.1016/j.apsb.2021.05.016 ↗
69. 10.1002/adma.20190253010.1002/adma.201902530 ↗
70. 10.1038/s41467-019-10847-010.1038/s41467-019-10847-0 ↗
71. 10.1021/jacs.9b1278810.1021/jacs.9b12788 ↗
72. 10.1016/j.nantod.2022.10143910.1016/j.nantod.2022.101439 ↗
73. Zhang J. · Angew. Chem., Int. Ed. · 2022 · 62